Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adeshwar MeditexBOM:543309 66 Receivables Turnover is 0.98 as of Mar. 2026. GuruFocus rates BOM:543309 with a GF Score™ of 66/100 and a GF Value™ of ₹14.83 (Fairly Valued). The stock has 5 warning signs investors should review. Among 810 Medical Devices & Instruments companies, Adeshwar Meditex ranks worse than 94.44% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Adeshwar Meditex's Revenue for the
six
months ended in Mar. 2026 was ₹260.5 Mil. Adeshwar Meditex's average Accounts Receivable for the
six
months ended in Mar. 2026 was ₹266.5 Mil.
Hence, Adeshwar Meditex's Receivables Turnover for the
six
months ended in Mar. 2026 was 0.98.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Adeshwar Meditex Receivables Turnover Related Terms
Adeshwar Meditex Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Adeshwar Meditex's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543309 vs ISRG, BDX, RMD: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, Adeshwar Meditex's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adeshwar Meditex Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adeshwar Meditex's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Adeshwar Meditex's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adeshwar Meditex (BOM:543309) has a Receivables Turnover of 0.98 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Adeshwar Meditex and its competitors. According to the industry distribution chart, Adeshwar Meditex ranks #765 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 94.4%.
Is Adeshwar Meditex's Receivables Turnover too high?
Adeshwar Meditex's current Receivables Turnover is 0.98. The Medical Devices & Instruments industry median Receivables Turnover is 5.62. Adeshwar Meditex's value of 0.98 is 82.5% below this industry median. Based on the distribution chart, Adeshwar Meditex ranks #765 out of 810 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Adeshwar Meditex has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Adeshwar Meditex's Receivables Turnover compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Adeshwar Meditex ranks #765 out of 810 companies for Receivables Turnover. This places Adeshwar Meditex in the lower half of its industry. The industry median Receivables Turnover is 5.62. Adeshwar Meditex's value of 0.98 is 82.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.62, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adeshwar Meditex's current Receivables Turnover of 0.98 is 82.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Adeshwar Meditex and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adeshwar Meditex's current Receivables Turnover is 0.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adeshwar Meditex stock overvalued right now?
Based on GuruFocus' analysis, Adeshwar Meditex (BOM:543309) is currently considered Fairly Valued. The stock's GF Value™ is ₹14.83, compared to a current price of ₹16.30 — trading 9.9% above its estimated fair value. The current Receivables Turnover is 0.98 and 82.5% below the Medical Devices & Instruments industry median of 5.62. Adeshwar Meditex's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Adeshwar Meditex (BOM:543309), the current Receivables Turnover is 0.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adeshwar Meditex (BOM:543309) Overvalued in 2026?
Based on GuruFocus' analysis, Adeshwar Meditex stock appears to be overvalued.
The current stock price of ₹16.30 is trading 9.9% above its estimated GF Value™ of ₹14.83.
GuruFocus considers Adeshwar Meditex to be Fairly Valued.
Key valuation signals for BOM:543309:
Receivables Turnover: 0.98
GF Value™: ₹14.83 vs. price of ₹16.30 (9.9% above fair value)
Industry Position: 82.5% below the Medical Devices & Instruments median (#765 of 810)
No single metric tells the full story. See the BOM:543309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adeshwar Meditex Ltd is engaged in manufacturing surgical dressings and external preparations products such as Sterile surgical wound dressing, Combine dressing, Gauze Dressing and Cotton Products, Medical Bandages and Plaster, Antiseptics / Disinfectants, and others.
66GF Score
Get the complete analysis for BOM:543309
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543309 has been successfully added to your 
